Understanding Patients' Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market.

Murthy, Sreenivasa; Aneja, Pankaj; Asirvatham, Arthur Joseph; Husemoen, Lise Lotte N; Rhee, Nicolai A; Kesavadev, Jothydev

Murthy, Sreenivasa; Aneja, Pankaj; Asirvatham, Arthur Joseph; Husemoen, Lise Lotte N; Rhee, Nicolai A; Kesavadev, Jothydev.

Afiliação

Murthy S; LifeCare Hospital and Research Centre, Bangalore, Karnataka, India. drsreenivasamurthy@gmail.com.
Aneja P; Max Super Speciality Hospital, Shalimar Bagh, New Delhi, India.
Asirvatham AJ; Arthur Asirvatham Hospital, Madurai, Tamil Nadu, India.
Husemoen LLN; Novo Nordisk A/S, Søborg, Denmark.
Rhee NA; Novo Nordisk Health Care AG, Zurich, Switzerland.
Kesavadev J; Jothydev's Diabetes Research Center, Trivandrum, Kerala, India.

Pharmacoecon Open ; 5(2): 261-273, 2021 Jun.

Article em En | MEDLINE | ID: mdl-33410093

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Pharmacoecon Open Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google